At the 2023 Grand Challenges Annual Meeting, Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale.
Strong organic growth in core markets underscores resilience of Dermapharm Holding SE’s corporate strategy – Biotech Investments
EQS-News: Dermapharm Holding SE / Key word(s): Quarterly / Interim Statement/Quarter Results Strong organic growth in core markets underscores resilience of Dermapharm Holding SE’s corporate